FORM4API
ExploreSearch any ticker for its insider tradesFilingsThe newest Form 4 filings, market-wideForm 144Intent to sell, filed before the trade13F FilersInstitutional 13F-HR filers by AUMSignalsCluster buy & sell signalsScreenerFilter trades by code, size & returnCongressSTOCK Act trades disclosed by Congress
PricingDocs
SEC Form 4 explainedSEC Form 144 explained13F-HR filings explainedCluster buy signals10b5-1 trading plans
All guides →
Sign inGet a key

Company profile

Bright Minds Biosciences Inc. Insider Trading

DRUG

Every SEC Form 4 insider trading filing for Bright Minds Biosciences Inc. (DRUG) since April 2023 — open-market buys and sells by directors and officers, option exercises, and cluster activity, updated as each filing is reported to the SEC. Why 2023?

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
CIK
0001827401
Filings
3
Insiders
3
Last filing
2026-04-28
SEC EDGAR ↗Yahoo Finance ↗Finviz ↗Stock Analysis ↗

Activity summary

No insider transactions in the last 30 days. The most recent was on April 28, 2026, when Cormorant Asset Management, LP sold 109,331 shares. 3 filings from 3 insiders are on record below.

Quarterly balance

Buy and sell value by quarter, Q4 24 to Q2 26. Bright Minds Biosciences Inc. insiders are net sellers across the period shown.

PurchasesSales
Q4 24Q1 25Q2 25Q3 25Q4 25Q1 26$9.8MQ2 26

Bars below the rule are sales, above are purchases. Largest quarter on the chart is $9.8M.

No insider activity recorded for DRUG in the last 90 days.

Insider Transactions

Sourced from SEC EDGAR Form 4 filings. Updated hourly.

DateInsiderCompanyTypeSharesPriceValueReturn
Apr 28, 2026Cormorant Asset Management, LPDRUG
Sale
109,331$89.50$9.79M-16.7% 3m
Nov 4, 2024Cormorant Asset Management, LPDRUG
Purchase
184,331$21.70$4.00M-41.5% 6m
Oct 16, 2024Cormorant Asset Management, LPDRUG
Purchase
39,743$23.21$923K+54.4% 6m
Oct 16, 2024Cormorant Asset Management, LPDRUG
Purchase
7,150$24.03$172K+54.4% 6m
Oct 16, 2024Cormorant Asset Management, LPDRUG
Purchase
3,107$25.22$78K+54.4% 6m

8 more transactions hidden

Free account · No credit card required

Building something? Get API access →

Query this yourself

The same rows, over the API.

curl "https://api.form4api.com/v1/transactions?ticker=DRUG" \
  -H "X-Api-Key: $KEY"
Get a key

Institutional Ownership

Top 13F-HR holders of Bright Minds Biosciences Inc. as of 2026-06-30

— stable
Total reported AUM
$65.1M
QoQ change
—
Reporting period
2026-06-30
#1
BlackRock, Inc.
CIK 0002012383
$20.5M
292K shares
#2
BlackRock, Inc.
CIK 0002012383
$10.7M
153K shares
#3
State Street Corp
CIK 0000093751
$8.6M
122K shares

Data source: quarterly 13F-HR filings — institutional holders report positions within 45 days of quarter end. Joined with insider activity above — see who's loading up institutionally while insiders are trading. Full 13F-HR API →

FORM4API

Real-time SEC Form 4, Form 144, 13F-HR and congressional trading data, over a REST API and webhooks.

Data
  • Screener
  • Filings
  • Signals
  • Companies
  • Insiders
  • Congress trades
  • 13F filers
  • Explorer
  • Top insiders
Developers
  • Documentation
  • Insider trading API
  • Python SDK
  • TypeScript SDK
  • MCP server
  • Status
Company
  • Pricing
  • Guides
  • Compare
  • About
  • Data quality
  • Privacy
  • Terms
Form4API, StockholmNot affiliated with the SEC or EDGAR. Data sourced from public EDGAR filings. Not investment advice.

Popular companies on Form4API

Browse insider trading activity for other actively-filed companies.

TEAMAtlassian CorpLEGLeggett & Platt IncVZVerizon Communications IncTPLTexas Pacific Land CorpCRMSalesforce, Inc.RCGRENN Fund, Inc.METAMeta Platforms, Inc.ACNAccenture plcPPGPpg Industries IncNFLXNetflix IncCHDChurch & Dwight Co Inc /de/